Industry funding of academic research

Last updated

Industry funding of academic research in the United States is one of the two major sources of research funding in academia along with government support. Currently, private funding of research accounts for the majority of all research and development funding in the United States as of 2007 overall. [1] Overall, Federal and Industrial sources contribute similar amounts to research, while industry funds the vast majority of development work. [1]

Contents

While the majority of industry research is performed in-house, a major portion of this private research funding is directed to research in non-profit academic centers. [2] As of 1999, industrial sources accounted for an estimated $2.2 billion of academic research funding in the US. [2] However, there is little governmental oversight or tracking of industry funding on academic science and figures of the scale of industry research are often estimated by self-reporting and surveys which can be somewhat unreliable.

Much of this industry funding of academic research is directed toward applied research. However, by some accounts, industry may even fund up to 40% of basic research in the United States, with Federal funding of basic research falling below 50%, although this figure does not consider where this research is conducted. [3] The role for funding of academic research from industrial sources has received much attention both in a historical and contemporary perspective. [4] The practice has received both extensive political praise and scholarly criticism.[ citation needed ]

History

Research in the US prior to World War II, heavily relied on funding from private sources without major organized federal research programs or either the scientists’ or associates’ personal funds. During WWII, governmental investment in research was widely regarded as a major contributor to military success and support for research was politically favorable. [5] Following WW2, federal research funding in both Europe and the US increased in terms of relative percent of funding for research and absolute amount. [5] Overall, the growth of industrial research funding has greatly outpaced public research funding growth, with US governmental research funding increasing by an average of 3.4% annually, while industrial research funding increased by an average of 5.4% annually from 1950 to 2004. [1]

Since WW2, industry funding of science has consistently represented the second largest source of funding for academic science. [6] Industry funding of academic science did expand during the 1980s and 1990s following the passing of the Bayh–Dole Act and a variety of both State and Federal proposals to increase funding for joint industry academic partnerships. [7] In the 2000s there has been a small retraction of industry funding for academic science while overall industry R&D funding has expanded. [6] ). However, industry funding may be broadening its scope as industry funding of basic science increasing dramatically over that same period, but much of this funding remains in-house. [3]

Culturally, attitudes towards the industrial funding of academic research have changed over time. Within universities, commercial activities and industry funding were often spurned in the 19th century. [8] More recently, commercializing scientific activity is viewed more favorably with extensive political and university support of translating scientific discovery into economic output. However, within the research community and the public, industrial funding of research remains controversial. The universality of this tangled industry, academic, and governmental exchange of funding and research adventures has led researchers to term this model of R&D the Triple Helix. [9]

Types of industrially funded academic research

University-industry partnerships can take on a variety of forms. On the smallest scale, individual research labs or researchers can partner with industry sources for funding. The details of such partnerships can differ substantially with any number of motives ranging from the academic lab testing of previously developed products, to performing early stage basic research related to industry research objectives, or even to individual researchers supporting their salary by consulting on related research problems in industry. [10] While many such partnerships exist, due to their informal nature and resulting lack of record, it is difficult to track how extensive and impactful such relationships are, with most relying on surveys and other self-reporting measures. By closest approximation, according to the Research Value Mapping Survey, 17% of academics at major US research universities report receive grants from industry sources supporting their research. [11]

Far more extensively, in many fields and countries, a narrow majority of academic scientists report having some soft industry relationships, primarily through consulting. [12] [13] Such informal industry academic relationships have a long-standing tradition as they served as a major source of funding for individual labs prior to WW2. In many cases, it was expected that researchers would pursue such relationships as this was expected to be a major source of funding for researcher’s salaries. [10] Despite greatly expanded post-WW2 federal support for research, so called soft money salary support from industry remains a large and growing aspect of academic research salaries. [12]

University Industry Research Centers (UIRCs)

On a larger scale, there have been numerous attempts to create collaborative University-Industry Research Centers (UIRCs) to jointly host academic and industry researchers to address industry problems with direct, large scale collaborative centers. Early forms of UIRCS started in the 1950s and 1960s with the formation of research parks with industry sponsors. In the 1970s, there were multiple proposals at the federal level in the US to help fund and expand early UIRCs. However, funding fell through at multiple points. [14]

The first UIRCs experienced difficulties in bridging the differences between academic and industrial culture. One such attempt occurred at Cal Tech where Cal Tech researchers partnered with Xerox and IBM through the Silicon Structures Project. [15] Both industry and academic partners were concerned about the cultures of the other and found the structure ineffective. [12] With such frustrations, it was difficult to secure partners to continue expanding UIRCs.[ citation needed ]

In the late 1970s, RPI created two three new UIRCs: 1) the Center for Integrated Computer Graphics, which received both NSF and industry support 2) the Center for Manufacturing Productivity and Technology Transfer, which was funded entirely by industry support and 3) the Center for Integrated Electronics, which received unprecedented industry support. [14] These centers were generally regarded as highly successful and made expansion of governmental support for joint industry and academic ventures more favorable. In the early 1980s, states began contributing funding to UIRCs and other industry-academic partnerships to encourage local economic growth from innovation. By the mid-1980s, the federal government expanded financial support for UIRCs. [16]

With mixed governmental and industry support, the UIRCs were more likely to be successful. Over time successful governmentally funded UIRCs could become independent from government support once having demonstrable successes that could continue to incentivize industry to contribute funding more aggressively. [14] UIRCs, coupled to early seeding from both state and federal government, continued to greatly expand during the 1980s and early 1990s, eventually receiving nearly 70% of industry funding of academic research and incentivizing a tripling of industry funding of academic research during the 1980s. [7]

Contract Research Organizations (CROs)

Contract research has also drawn increasing industry funding, particularly to Contract Research Organizations (CROs) from Biotech and Pharmaceutical corporations. [17] Contract research is a popular form of outsourcing research in industry as industry has more influence over how the study is conducted than in either UIRCs or traditional academic grants. CROs, which are specifically designed for this function have drawn substantial industry clinical research funding away from academia and are growing rapidly. [18]

Influence and criticisms

Much discussion has been placed on the effects of industrial research funding on the behavior of academic research scientists. Concerns center on whether researchers can remain impartial when they are being funded by a for-profit and potentially motivated industrial source, if this funding gives private sources an oversized impact on which research directions are pursued, and the potential negative effects of industrial funding on the openness of science. [19]

A multitude of studies have found that pharmaceutical studies funded by industry organizations are significantly more likely to publish results in favor of the product being supported. [20] This could, in part, be due to the fact that usually when an academic accepts industry funding, particularly when working on an existing product, researchers have to sign non-disclosure agreements which often prevent the publication of negative results and inhibit the openness of science. [21] This could serve to significantly bias scientific results and diminish public trust of science.[ citation needed ]

There are additionally many scholars who have considered advantages of industrially funded academic research. Generally, increased industry funding may increase academic and industry interaction, prompting greater efficiency in translating and commercializing of science research. This increased commercialization activity from academics could serve as an economic and societal boost as the economy could be bolstered by new products hitting the market, while society could benefit directly from having increased access to the fruits of scientific production. Supporting this, academic science funded by industry sources does result in more patents per dollar, increased licensing of these patents, and even more citations per published paper than research supported by other sources, including federal at the University of California Berkeley. [22]

In Germany, it also appears that applied research funded by industry sources results in a significant increase in patent citations, which could correspond to a serious increase in translation of applied research. [23] Such increase in commercialization and translation of research could provide social and economic benefits. [23] However, it is difficult to determine whether this increase in apparent impact is due to the industry funding itself or is just a read out that industry funds target work that tends to produce more citations per publication as well as more patents. [6]

See also

Related Research Articles

<span class="mw-page-title-main">National Center for Supercomputing Applications</span> Illinois-based applied supercomputing research organization

The National Center for Supercomputing Applications (NCSA) is a state-federal partnership to develop and deploy national-scale computer infrastructure that advances research, science and engineering based in the United States. NCSA operates as a unit of the University of Illinois Urbana-Champaign, and provides high-performance computing resources to researchers across the country. Support for NCSA comes from the National Science Foundation, the state of Illinois, the University of Illinois, business and industry partners, and other federal agencies.

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

<span class="mw-page-title-main">National Science Foundation</span> United States government agency

The National Science Foundation (NSF) is an independent agency of the United States federal government that supports fundamental research and education in all the non-medical fields of science and engineering. Its medical counterpart is the National Institutes of Health. With an annual budget of about $8.3 billion, the NSF funds approximately 25% of all federally supported basic research conducted by the United States' colleges and universities. In some fields, such as mathematics, computer science, economics, and the social sciences, the NSF is the major source of federal backing.

Technology transfer (TT), also called transfer of technology (TOT), is the process of transferring (disseminating) technology from the person or organization that owns or holds it to another person or organization, in an attempt to transform inventions and scientific outcomes into new products and services that benefit society. Technology transfer is closely related to knowledge transfer.

Science and technology in Israel is one of the country's most developed sectors. Israel spent 4.3% of its gross domestic product (GDP) on civil research and development in 2015, the highest ratio in the world. In 2019, Israel was ranked the world's fifth most innovative country by the Bloomberg Innovation Index. It ranks thirteenth in the world for scientific output as measured by the number of scientific publications per million citizens. In 2014, Israel's share of scientific articles published worldwide (0.9%) was nine times higher than its share of the global population (0.1%).

<span class="mw-page-title-main">Big science</span> Term used to describe a series of changes in science occurred in industrial nations

Big science is a term used by scientists and historians of science to describe a series of changes in science which occurred in industrial nations during and after World War II, as scientific progress increasingly came to rely on large-scale projects usually funded by national governments or groups of governments. Individual or small group efforts, or small science, are still relevant today as theoretical results by individual authors may have a significant impact, but very often the empirical verification requires experiments using constructions, such as the Large Hadron Collider, costing between $5 and $10 billion.

<span class="mw-page-title-main">Richard C. Atkinson</span> American educational psychologist and academic

Richard Chatham Atkinson is an American professor of psychology and cognitive science and an academic administrator. He is president emeritus of the University of California system, former chancellor of the University of California, San Diego, and former director of the National Science Foundation.

Research funding is a term generally covering any funding for scientific research, in the areas of natural science, technology, and social science. Different methods can be used to disburse funding, but the term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and only the most promising receive funding. It is often measured via Gross domestic expenditure on R&D (GERD).

<span class="mw-page-title-main">National Renewable Energy Laboratory</span> United States national laboratory

The National Renewable Energy Laboratory (NREL) in the US specializes in the research and development of renewable energy, energy efficiency, energy systems integration, and sustainable transportation. NREL is a federally funded research and development center sponsored by the Department of Energy and operated by the Alliance for Sustainable Energy, a joint venture between MRIGlobal and Battelle. Located in Golden, Colorado, NREL is home to the National Center for Photovoltaics, the National Bioenergy Center, and the National Wind Technology Center.

<span class="mw-page-title-main">Medical research</span> Wide array of research

Medical research, also known as experimental medicine, encompasses a wide array of research, extending from "basic research", – involving fundamental scientific principles that may apply to a preclinical understanding – to clinical research, which involves studies of people who may be subjects in clinical trials. Within this spectrum is applied research, or translational research, conducted to expand knowledge in the field of medicine.

Through history, the systems of economic support for scientists and their work have been important determinants of the character and pace of scientific research. The ancient foundations of the sciences were driven by practical and religious concerns and or the pursuit of philosophy more generally. From the Middle Ages until the Age of Enlightenment, scholars sought various forms of noble and religious patronage or funded their own work through medical practice. In the 18th and 19th centuries, many disciplines began to professionalize, and both government-sponsored "prizes" and the first research professorships at universities drove scientific investigation. In the 20th century, a variety of sources, including government organizations, military funding, patent profits, corporate sponsorship, and private philanthropies, have shaped scientific research.

The Science and Technology Facilities Council (STFC) is a United Kingdom government agency that carries out research in science and engineering, and funds UK research in areas including particle physics, nuclear physics, space science and astronomy.

Slow science is part of the broader slow movement. It is based on the belief that science should be a slow, steady, methodical process, and that scientists should not be expected to provide "quick fixes" to society's problems. Slow science supports curiosity-driven scientific research and opposes performance targets. Slow science is a continually developing school of thought in the scientific community. Followers of slow science practices are generally opposed to the current model of research which is seen as constrained by the need for continued funding. The slow science perspective attributes the overinflation of scientific publishing, and rise in fraudulent publishing with the requirement for researchers and institutions to create a justification for continued funding. The term slow science was first popularised in “Another Science is Possible: A Manifesto for Slow Science” by researcher Isabelle Stengers in 2018. The idea of “publish or perish”, which too links limitations in the quality of research to financial constraints, has been around since the early 20th century. The slow science philosophy has been described as both a way to approach scientific research, and a science led movement which acts as a critique of science's function in neoliberal society.

<span class="mw-page-title-main">Ministry of Science and Technology (China)</span> Government ministry of the Peoples Republic of China

The Ministry of Science and Technology is the fifth-ranked executive department of the State Council of the People's Republic of China, which coordinates science and technology activities in the country. The office is located in Xicheng District, Beijing.

The Swiss Federal Laboratories for Materials Science and Technology is a Swiss research institution for application-oriented materials science and technology. It has three locations – Dübendorf, St. Gallen and Thun. As part of the ETH Domain, it is assigned to the Federal Department of Economic Affairs, Education and Research (EAER). For more than 100 years since its foundation in 1880, Empa has been a material testing institute. Since the late 1980s, it has increasingly transformed into an interdisciplinary research institute for materials and technologies.

<span class="mw-page-title-main">Science and technology in Morocco</span>

Science and technology in Morocco has significantly developed in recent years. The Moroccan government has been implementing reforms to encourage scientific research in the Kingdom. While research has yet to acquire the status of a national priority in Morocco, the country does have major assets that could transform its R&D sector into a key vehicle for development. The industry remains dominated by the public sector, with the universities employing 58% of researchers. Morocco's own evaluation of its national research system – carried out in 2003 – revealed that the country has a good supply of well trained high quality human resources and that some laboratories are of very high quality. However, the greatest gap at that point of time lied in the link between research and innovation. The educational qualifications of Moroccan researchers have increased significantly since the early 1990s. The University of Al-Karaouine is considered the oldest continuously operating academic degree-granting university in the world.

Science and technology in Kazakhstan – government policies to develop science, technology and innovation in Kazakhstan.

Science and technology in Uzbekistan examines government efforts to develop a national innovation system and the impact of these policies.

University technology transfer offices (TTOs), or technology licensing offices (TLOs), are responsible for technology transfer and other aspects of the commercialization of research that takes place in a university. TTOs engage in a variety of commercial activities that are meant to facilitate the process of bringing research developments to market, often acting as a channel between academia and industry. Most major research universities have established TTOs in the past decades in an effort to increase the impact of university research and provide opportunities for financial gain. While TTOs are commonplace, many studies have questioned their financial benefit to the university.

The common definition of academic entrepreneur is similar to the original definition of ‘entrepreneur.’ It states “the AE is a university scientist, most often a professor, sometimes a PhD student or a post-doc researcher, who sets up a business company in order to commercialize the results of his/her research” Academic entrepreneurship today can be understood as either:

References

  1. 1 2 3 Federal Support for Research and Development. Congressional Budget Office (Report). June 2007.
  2. 1 2 McGeary, Michael; Hanna, Kathi E., eds. (2004). "Sources of Funding for Biomedical Research". Strategies to Leverage Research Funding. National Academies Press (US). pp. 37–54. ISBN   978-0-309-09277-7.
  3. 1 2 Mervis, Jeffrey (2017). "Data check: U.S. Government share of basic research funding falls below 50%". Science. doi:10.1126/science.aal0890.
  4. Chopra, S. S (2003). "Industry Funding of Clinical Trials: Benefit or Bias?". JAMA. 290 (1): 113–4. doi:10.1001/jama.290.1.113. PMID   12837722.
  5. 1 2 Bloom, Floyd E.; Randolph, Mark A. (1990). "Funding for Health Sciences Research". Funding Health Sciences Research: A Strategy to Restore Balance. National Academies Press.
  6. 1 2 3 Jahnke, Art (April 6, 2015). "Who Picks Up the Tab for Science?". BU Today.
  7. 1 2 Cohen, Wesley; Florida, Richard; Goe, W Richard (1994). University-Industry Research Centers in the United States: Final Report to the Ford Foundation. H. John Heinz III School of Public Policy and Management, Center for Economic Development. OCLC   249390310.[ page needed ]
  8. Lucier, Paul (2009). "The Professional and the Scientist in Nineteenth-Century America". Isis. 100 (4): 699–732. doi:10.1086/652016. PMID   20380344. S2CID   23927685.
  9. Etzkowitz, Henry; Leydesdorff, Loet (2000). "The dynamics of innovation: From National Systems and 'Mode 2' to a Triple Helix of university–industry–government relations". Research Policy. 29 (2): 109–23. doi:10.1016/S0048-7333(99)00055-4.
  10. 1 2 Lucier, Paul (2008). Scientists and Swindlers: Consulting on Coal and Oil in America, 1820–1890. Johns Hopkins University Press. ISBN   978-1-4214-0285-7. Project MUSE   book 3500.[ page needed ]
  11. Bozeman, Barry; Gaughan, Monica (2007). "Impacts of grants and contracts on academic researchers' interactions with industry". Research Policy. 36 (5): 694–707. doi:10.1016/j.respol.2007.01.007.
  12. 1 2 3 Perkmann, Markus; Tartari, Valentina; McKelvey, Maureen; Autio, Erkko; Broström, Anders; D’Este, Pablo; Fini, Riccardo; Geuna, Aldo; Grimaldi, Rosa; Hughes, Alan; Krabel, Stefan; Kitson, Michael; Llerena, Patrick; Lissoni, Franceso; Salter, Ammon; Sobrero, Maurizio (March 2013). "Academic engagement and commercialisation: A review of the literature on university–industry relations". Research Policy. 42 (2): 423–442. doi: 10.1016/j.respol.2012.09.007 . hdl: 10261/104445 .
  13. Zinner, D. E; Bolcic-Jankovic, D; Clarridge, B; Blumenthal, D; Campbell, E. G (2009). "Participation of Academic Scientists in Relationships with Industry". Health Affairs. 28 (6): 1814–25. doi:10.1377/hlthaff.28.6.1814. PMC   3767010 . PMID   19887423.
  14. 1 2 3 Berman, Elizabeth Popp (2012). Creating the Market University. doi:10.23943/princeton/9780691147086.001.0001. ISBN   978-0-691-14708-6.[ page needed ]
  15. Mead, Carver (12 February 1980). Silicon Structures Project.
  16. Slaughter, Sheila; Rhoades, Gary (2016). "The Emergence of a Competitiveness Research and Development Policy Coalition and the Commercialization of Academic Science and Technology". Science, Technology, & Human Values. 21 (3): 303–39. doi:10.1177/016224399602100303. JSTOR   689710. S2CID   145126691.
  17. Crawshaw, Bruce (1985). "Contract research, the university, and the academic". Higher Education. 14 (6): 665–82. doi:10.1007/BF00136504. JSTOR   3446795. S2CID   144877329.
  18. Carroll, J (2005). "CRO Crowing About Their Growth". Biotechnology Healthcare. 2 (6): 46–50. PMC   3571008 . PMID   23424323.
  19. Behrens, Teresa R; Gray, Denis O (2001). "Unintended consequences of cooperative research: Impact of industry sponsorship on climate for academic freedom and other graduate student outcome". Research Policy. 30 (2): 179–99. doi:10.1016/S0048-7333(99)00112-2.
  20. Sismondo, Sergio (2008). "How pharmaceutical industry funding affects trial outcomes: Causal structures and responses". Social Science & Medicine. 66 (9): 1909–14. CiteSeerX   10.1.1.404.9508 . doi:10.1016/j.socscimed.2008.01.010. PMID   18299169. S2CID   2209683.
  21. McCluskey, Molly (3 April 2017). "Public Universities Get an Education in Private Industry". The Atlantic.
  22. Wright, Brian D; Drivas, Kyriakos; Lei, Zhen; Merrill, Stephen A (2014). "Technology transfer: Industry-funded academic inventions boost innovation". Nature. 507 (7492): 297–9. doi: 10.1038/507297a . PMID   24654278.
  23. 1 2 Hottenrott, Hanna; Thorwarth, Susanne (November 2011). "Industry Funding of University Research and Scientific Productivity: Industry Funding of University Research and Scientific Productivity" (PDF). Kyklos. 64 (4): 534–555. doi:10.1111/j.1467-6435.2011.00519.x.